新生儿呼吸窘迫综合征是新生儿肺泡功能发育不全导致的肺泡表面活性物质缺乏而引发的疾病,对新生儿的生命健康构成了严重的威胁。目前针对该病采取从产前预防至发病治疗的综合防治策略,包括产前保健管理、产后维持新生儿状况稳定、肺泡表面活性物质应用、支持治疗和相关医疗资源的合理配置。 Neonatal respiratory distress syndrome is a disease caused by the lack of alveolar surfactant caused by hypospadias in neonates, which poses a serious threat to the life and health of the newborn. At present, a comprehensive prevention and treatment strategy is taken from prenatal prevention to morbidity for the disease, including prenatal care management, stable postnatal maintenance of newborn, rational use of alveolar surfactant, supportive care and related medical resources.